0|582|Public
50|$|<b>Bausch</b> + <b>Lomb</b> was in {{a lawsuit}} with Novartis which claimed to have patents on a <b>Bausch</b> + <b>Lomb</b> product called PureVision. On June 26, 2002, a federal judge ruled that <b>Bausch</b> & <b>Lomb</b> did {{infringe}} on Ciba Vision (a subsidiary of Alcon) patents.|$|R
50|$|Legacy Tower (formerly <b>Bausch</b> & <b>Lomb</b> Place) is a {{skyscraper}} {{located in}} Rochester, New York. It {{is the second}} tallest building in Rochester, standing at 401 feet (122 meters) with 20 floors. It was constructed {{to be the world}} headquarters for the eye-care company <b>Bausch</b> & <b>Lomb.</b> After <b>Bausch</b> & <b>Lomb</b> left in 2014, the tower was sold to three local developers.|$|R
50|$|In 2011, ISTA {{pharmaceuticals}} {{experienced a}} 2.4% increase in net revenues from 2010, which {{was driven by}} the sales of Bepreve. Their net revenue for 2011 was $160.3 million. ISTA Pharmaceuticals was acquired by <b>Bausch</b> & <b>Lomb</b> in March 2012 for $500 million. <b>Bausch</b> & <b>Lomb</b> hold the patent for bepotastine besilate (https://www.accessdata.fda.gov/scripts/cder/ob/docs/temptn.cfm. On November 26, 2014, <b>Bausch</b> & <b>Lomb</b> sue Micro Labs USA for patent infringement. <b>Bausch</b> & <b>Lomb</b> was recently bought out by Valeant Pharmaceuticals in May 2013 for $8.57 billion, Valeant's largest acquisition to date, causing the company's stock to rise 25% when the deal was announced.|$|R
5000|$|Aviator {{sunglasses}} are a {{style of}} sunglasses that were developed by <b>Bausch</b> & <b>Lomb.</b> The original <b>Bausch</b> & <b>Lomb</b> design is now marketed as Ray-Ban Aviators, although other manufacturers also produce aviator style sunglasses.|$|R
50|$|He {{served as}} the CEO of <b>Bausch</b> & <b>Lomb</b> Incorporated and <b>Bausch</b> & <b>Lomb</b> Holdings Incorporated since March 15, 2010. He served as a Special Adviser of General Atlantic LLC. From 2010 to February 2013, he served as President of <b>Bausch</b> & <b>Lomb</b> Holdings Incorporated. He served as an Advisor of Valeant Pharmaceuticals since August 2013. Saunders {{served as the}} C.E.O. and President of Forest Laboratories from October 1, 2013 to 2014.|$|R
5000|$|<b>Bausch</b> & <b>Lomb</b> (US) - has {{not made}} {{binoculars}} since 1976, when they licensed their name to Bushnell, Inc., who made binoculars under the <b>Bausch</b> & <b>Lomb</b> name until the license expired, and was not renewed, in 2005.|$|R
50|$|According to a {{preliminary}} report released by the FDA on May 16, 2006, <b>Bausch</b> & <b>Lomb</b> failed to notify the FDA that Singapore's Ministry of Health reported 35 serious cases of Fusarium keratitis to <b>Bausch</b> & <b>Lomb</b> in February 2006.|$|R
50|$|<b>Bausch</b> and <b>Lomb</b> Honorary Science Award.|$|R
25|$|Valeant Pharmaceuticals: {{through its}} <b>Bausch</b> & <b>Lomb</b> subsidiary.|$|R
50|$|<b>Bausch</b> and <b>Lomb</b> Merit Award for Physics, U.S.A.|$|R
50|$|Valeant Pharmaceuticals: {{through its}} <b>Bausch</b> & <b>Lomb</b> subsidiary.|$|R
50|$|In 1943, <b>Bausch</b> and <b>Lomb</b> {{themselves}} filed {{a patent}} for a similar, f/6.3 lens design but with 5 elements, under the US patent number 2325275, showing less distortion than the lens in the Carl Zeiss patent. It {{is not certain}} whether <b>Bausch</b> and <b>Lomb</b> incorporated their own design instead of the Zeiss design when producing lenses under the Metrogon name later on. The <b>Bausch</b> and <b>Lomb</b> patent also compares the distortion of their design favorably to another 5 element lens (US patent number 2116264) which has a slightly wider maximum f-number of f/5.6.|$|R
5000|$|... #Article: 1999 <b>Bausch</b> & <b>Lomb</b> Championships - Singles Qualifying ...|$|R
5000|$|... #Caption: <b>Bausch</b> & <b>Lomb</b> Convertible Balopticon projector, circa 1913 ...|$|R
5000|$|... #Caption: Using the <b>Bausch</b> & <b>Lomb</b> Spectronic 20 Colorimeter, 1962 ...|$|R
50|$|The 1999 <b>Bausch</b> & <b>Lomb</b> Championships - Singles was the singles {{event of}} the twentieth edition of the <b>Bausch</b> & <b>Lomb</b> Championships; a WTA Tier II tournament held in Amelia Island, Florida, United States, played on green clay. Mary Pierce was the {{defending}} champion but lost in the quarterfinals to Conchita Martínez.|$|R
50|$|The women's doubles {{draw for}} the 2008 <b>Bausch</b> & <b>Lomb</b> Championships.|$|R
5000|$|Contact Lenses - Johnson & Johnson, <b>Bausch</b> & <b>Lomb,</b> {{and others}} ...|$|R
5000|$|Specialty Chemicals - Represents the {{regional}} interests of <b>Bausch</b> and <b>Lomb.</b>|$|R
5000|$|The 1999 <b>Bausch</b> & <b>Lomb</b> Championships - Doubles was the doubles {{event of}} the twentieth edition of the <b>Bausch</b> & <b>Lomb</b> Championships; a WTA Tier II tournament held in Amelia Island, Florida, United States, played on green clay. Sandra Cacic and Mary Pierce were the {{defending}} champions but lost in the quarterfinals to Lisa Raymond and Rennae Stubbs.|$|R
5000|$|... #Caption: [...] Schematic {{electrical}} {{diagram of the}} <b>Bausch</b> & <b>Lomb</b> Spectronic 20 Colorimeter ...|$|R
5000|$|... #Caption: <b>Bausch</b> & <b>Lomb</b> Place, the company's former {{headquarters}} in Rochester, New York ...|$|R
5000|$|... #Caption: New York {{headquarters}} of the <b>Bausch</b> & <b>Lomb</b> Optical Company in 1891 ...|$|R
40|$|A {{comparison}} was firstly done of {{the oxygen}} flux through the <b>Bausch</b> and <b>Lomb</b> Plano T lens, the <b>Bausch</b> & <b>Lomb</b> U 3 lens, and the Duragel 75 lens with a sensor on the normal eye. The {{results showed that}} the <b>Bausch</b> and <b>Lomb</b> Plano T lens was the best for use with the sensor probe. The sensor was then used to obtain a comparison with the normal oxygen flux through a therapeutic lens on keratoplastic eyes and eyes with bullous keratopathy. The results showed that both conditions had a lower oxygen consumption than normal and that eyes with bullous keratopathy predictably had the lowest value...|$|R
5000|$|... #Caption: Circle at <b>Bausch</b> & <b>Lomb</b> {{headquarters}} {{with the}} Xerox Tower in the background.|$|R
50|$|Ray-Ban is a {{brand of}} {{sunglasses}} and eyeglasses founded in 1937 by the American company <b>Bausch</b> & <b>Lomb.</b> The brand {{is best known for}} their Wayfarer and Aviator lines of sunglasses. In 1999, <b>Bausch</b> & <b>Lomb</b> sold the brand to the Italian eyewear conglomerate Luxottica Group, for a reported US$640 million. Headquartered in Arkansas, the company has over 55,000 employees.|$|R
50|$|Recently, one {{particular}} product, ReNu with MoistureLoc brand of soft contact lens solutions made headlines regarding {{a report from}} the United States Centers for Disease Control and Prevention suggesting an increased incidence of a specific type of fungal keratitis (Fusarium keratitis) in people using <b>Bausch</b> & <b>Lomb</b> products. <b>Bausch</b> & <b>Lomb</b> subsequently suspended, then recalled, shipments of {{one particular}} product, ReNu with MoistureLoc.|$|R
50|$|<b>Bausch</b> + <b>Lomb,</b> an American company {{founded in}} Rochester, New York, {{is one of}} the world's largest {{suppliers}} of eye health products, including contact lenses, lens care products, medicines and implants for eye diseases. The company was founded in 1853 by an optician, John Jacob Bausch, and a financier, Henry Lomb. Its Ray-Ban brand of sunglasses was sold in 1999 to the Italian Luxottica Group. <b>Bausch</b> + <b>Lomb</b> was a public company listed on the NYSE until it was acquired by the private equity firm Warburg Pincus PLC in 2007. In May 2013, Valeant Pharmaceuticals agreed to buy <b>Bausch</b> + <b>Lomb</b> from Warburg Pincus LLC for $8.57 billion in cash. The deal, which was approved by share holders, included $4.2 billion earmarked to pay down <b>Bausch</b> + <b>Lomb</b> debt, and closed on August 5, 2013. Today, the company is headquartered in Bridgewater, New Jersey, and employs about 13,000 people in 36 countries.|$|R
50|$|Povidone {{is used as}} a {{lubricant}} in some eye drops, e.g. <b>Bausch</b> & <b>Lomb's</b> Soothe.|$|R
50|$|Saegmuller, {{as part of}} Fauth & Co., {{joined with}} <b>Bausch</b> & <b>Lomb</b> Optical Company in 1905.|$|R
50|$|The 1999 <b>Bausch</b> & <b>Lomb</b> Championships was a WTA tennis tournament, {{played on}} outdoor clay courts.|$|R
50|$|On July 2, 2004, {{the company}} {{announced}} that it had licensed the intellectual property of Novartis. <b>Bausch</b> & <b>Lomb</b> will pay the Ciba Vision unit of Novartis a royalty on net U.S. sales of its PureVision brand contact lenses until 2014 and on net sales outside the U.S. until 2016. But as of now, the brand FreshLook comes under <b>Bausch</b> and <b>Lomb</b> and Ciba manufacturers it.|$|R
50|$|On March 3, 2006, New Jersey {{ophthalmologist}} Dr. David S. Chu contacted <b>Bausch</b> & <b>Lomb</b> {{to report}} that three of his patients had contracted a fungal infection called Fusarium keratitis; {{all three of these}} patients were contact lens wearers who used <b>Bausch</b> & <b>Lomb's</b> Renu with MoistureLoc. Subsequently, he also reported his findings to the Centers for Disease Control and Prevention on March 8, 2006.|$|R
50|$|She is the {{spokesperson}} of <b>Bausch</b> & <b>Lomb</b> (Lacelle Series) (from 2011), IPSA and Forevermark (Diamond Ambassador).|$|R
5000|$|He {{has served}} as {{consultant}} of major optical companies including <b>Bausch</b> and <b>Lomb,</b> Ciba-Geigy, and American Hydron.|$|R
50|$|The 2008 <b>Bausch</b> & <b>Lomb</b> Championships - Singles was the singles {{event of}} the 2008 <b>Bausch</b> & <b>Lomb</b> Championships, a WTA Tier II tennis tournament held in April. Tatiana Golovin was the {{defending}} champion, but withdrew from this year's event with injury. Maria Sharapova defeated Dominika Cibulková in the final to become the 2008 champion. This was Sharapova's 19th career singles title but the first she had won on clay courts.|$|R
